Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameGlory Health
Stock Code02329
Company Full NameTo be extracted
Industry房地产
Principal Activities我們是中國一家高速成長的住宅物業開發商,並兼營商業物業業務。主要經營中國的住宅項目以及大型多用途綜合體項目,同時選擇性地保留優質商業物業作為租金來源,並承建一級土地開發項目以取得土地儲備。
Listing Date2014-07-07
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)北京市東城區珠市口東大街15號
Business Address (Hong Kong)香港港灣道18號中環廣場51樓5103A室
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitewww.glorypty.com
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 2.38 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer Period2014-06-23 to 2014-06-26
Global Offering Shares661,780,000 shares
HK Public Offer Shares (Initial)66,178,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)595,602,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO4,411,780,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share6.3%
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeHK$ 1,575,036,400

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 465.9M
Est. Threshold HK$ 9.71B
Analysis Result HK market cap below threshold, need +1985%

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約人民幣2,770.2百萬元
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 RMB
Income Statement
Item 201120122013
Revenue 1,753,3984,275,9966,835,358
Cost of sales -955,157-2,700,448-3,130,684
Gross profit 798,2411,575,5483,704,674
Other income and gains, net 11,06156,6978,426
Selling and distribution expenses -148,134-108,131-184,545
Administrative expenses -226,433-282,839-242,269
Net finance costs -192,970-230,039-572,542
Share of associates and JVs 11-650
Profit before tax 1,075,1072,033,6493,855,784
Income tax expense -330,686-760,471-1,085,595
Profit for the year 744,4211,273,1782,770,189
Profit attributable to owners 597,0011,029,7762,233,812
Balance Sheet
Item 201120122013
Cash and cash equivalents 589,266803,373844,854
Trade and bills receivables 1,580,914556,680389,494
Inventories 6,8338,14593
Total current assets 13,721,75411,379,92614,267,765
Total assets 20,284,79618,792,61122,467,403
Total current liabilities 10,069,0208,283,9018,451,791
Total liabilities 15,690,03113,107,11316,371,424
Total equity 4,594,7655,685,4986,095,979
Equity attributable to owners 3,802,0564,898,7334,788,414
Interest-bearing borrowings 5,623,8675,682,7807,336,560
Cash Flow Statement
Item 201120122013
Net cash from operating activities -1,531,17237,67532,901
Net cash from investing activities -232,316-502,183355,037
Net cash from financing activities 1,126,389678,615-346,457
Net increase in cash -637,099214,10741,481
Depreciation of PP&E 22,90722,97323,732
Amortisation of intangible assets 603818579
Purchase of PP&E -13,178-54,490-18,897
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 2.5
First Day OpenHK$ 2.32
First Day Change5.04%
First Day Volume6447000.0
First Day Turnover16288600.0
Use of Proceeds
1、約60%或約889.6百萬港元預期用于我們的物業開發項目,其中: a.約40%或約593.1百萬港元預期用于開發北京國瑞中心、沈陽國瑞城四期、海闊天空國瑞城四及五期項目,包括高層及超高層地標性甲級寫字樓; b.其余20%或約296.5百萬港元預期用于我們的其他物業開發項目,包括開發鄭州國瑞城六期及永清國瑞城四期; 2、約30%或約444.8百萬港元預期用于未來在我們目前經營所在城市和目標城市,特別是珠江三角洲,物色和收購合適的地塊作為我們的土地儲備; 3、其余10%或約148.3百萬港元將作我們的一般企業及營運資金用途。

Underwriting Syndicate

Sole Sponsor (1)
BOCI ASIA LIMITED CE AET863
Overall Coordinators (1)
BOCI ASIA LIMITED CE AET863
Joint Bookrunners (2)
BOCI ASIA LIMITED CE AET863 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650
Joint Lead Managers (2)
BOCI ASIA LIMITED CE AET863 CHINA MERCHANTS SECURITIES (HK) CO., LIMITED CE AAI650

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Best Class Industrial Limited 143,540,180 HKD — 1.37% — 6 months 2015-01-07
2 北京市第五建筑工程集团有限公司 233,368,520 HKD — 2.22% — 6 months 2015-01-07
3 中国生物制药有限公司 287,080,360 HKD — 2.73% — 6 months 2015-01-07

Directors & Management

PositionChinese nameEnglish Name
Chairman張章笋—
Company Secretary鄭瑾、鄺燕萍—
No director data available.

Major Shareholders

Major Shareholders & Holdings張主席透過通和持有3,716,382,300股股份,佔全球發售完成後已發行股本約84.238%
About this page

This page shows Glory Health (02329) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect